EventHealthNovember 19, 2026

Merck and Isomorphic Labs partner on AI drug discovery

Read original source →statnews.com

The research collaboration targets small molecule candidates for an undisclosed oncology target of "strategic importance." Isomorphic's drug design engine will pair with Merck's wet lab data; Merck handles preclinical and clinical development, manufacturing, and commercialization.

2 sources

More stories today

Open the live feed